Theophylline was measured with a Kodak Ektachem DTSC using its property of uncompetitive inhibition of alkaline phosphatase. Within-and betweenbatch reproducibility was satisfactory. Agreement with consensus mean values on quality assessment samples was good as was agreement on patients' samples with a high performance liquid chromatography reference method and an automated fluorescence polarisation immunoassay. At therapeutic theophylline concentrations, no interference was seen with caffeine, theobromine, 1,7-dimethylxanthine, 1,3dimethyl uric acid or 3-propylxanthine. 3-methylxanthine (a theophylline metabolite) gave a positive bias but the concentrations of this metabolite found in serum are such that the clinical significance of this finding is questionable. Salicylate at concentrations which might be found during therapy for paediatric rheumatoid arthritis also gave a positive bias.
Measurement of plasma theophylline concentration has been found to be a valuable aid to treatment with this drug because of significant inter-individual variation in theophylline metabolism, its dose related pharmacokinetics and its narrow therapeutic margin.
Ultraviolet spectrophotometric methods are not suitable for routine clinical use because of lack of specificity and sensitivity.' Gas liquid chromatography of theophylline is difficult without derivatisation and if alkylation is chosen the alkyl chain must be 2 carbon or longer to avoid interference from caffeine. High performance liquid chromatography (usually reverse phase) has been widely used and has the potential for separating theophylline from its metabolites and dietary xanthine derivatives which might interfere with theophylline measurement. This potential may be used to advantage when monitoring neonates treated with theophylline for apnoea, where measurement of caffeine (present as an active metabolite or following transplacental transfer) is also important. Immunoassays using a variety of labels (isotopic, enzymatic, fluorescent) have also gained a place in clinical analysis as they have advantages of speed and convenience over high performance liquid chromatography.
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Assays suitable for 'near patient' theophylline measurement are available. These include the Ames Seralyser'P", which uses apoenzyme reactivation immunoassay and the Syva Acculevel!", which uses immunochromatography. Methods of theophylline measurement and their problems have recently been reviewed. ' The inhibition of alkaline phosphatase activity by theophylline was first noted as a source of interference in alkaline phosphatase measurement: and was shown to be uncornpetitive." Inhibition was not shown by the majority of other naturally occurring xanthine derivatives and a theophylline assay based on inhibition has been proposed.' This principle has been adapted for the Kodak Ektachem 'dry' chemistry systems on large analysers and, more recently, for the DT60 bench top analyser using the DTSC reaction rate module.
In this study the Kodak Ektachem DTSC (DTSC) theophylline method was evaluated for imprecision and bias against automated fluorescence polarisation immunoassay (TD x ) and a high performance liquid chromatography reference method (HPLC). Interference from methyl xanthines, their metabolites and salicylate was also investigated with the objective of defining the place of the DTSC theophylline method in the clinical laboratory.
Materials and methods

KODAK EKTACHEM DTSC
Serum (10 JlI)was dispensed on to a slide placed in the spotting station of the DTSC module of the Ektachem DT60 analyzer (Eastman Kodak, Rochester, New York, USA) using the electronic pipette supplied. A spreading layer ensured uniform application of the sample over the slide and contained the alkaline phosphatase substrate p-nitrophenol phosphate which migrated with the sample through a screening/buffer layer (pH 8'2) to the reagent layer. In the reagent layer beefliver alkaline phosphatase hydrolysed the substrate yielding p-nitrophenol, the rate of formation of which was determined by measuring reflectance (400 nm) at 1·17 and 2·5 min after sample application. The reagent layer contained magnesium chloride and a mordant which stabilised the colour. The reagent layer was buffered at pH 8,2, the pH optimum for beef liver alkaline phosphatase. In the absence of theophylline the measured alkaline phosphatase activity was maximal. The measured activity was decreased in the presence of theophylline due to uncompetitive inhibition. Identification of the slide, timed reflectance readings and calculation of theophylline concentration from stored calibration data were performed automatically by the analyser. The manufacturer states that plasma can also be used for analysis if lithium or sodium heparin is used as anticoagulant. Magnesium chelating anticoagulants, for example EDTA, interfere with the assay.
The analyser was calibrated at the start of the study by analysing serum based calibrators containing theophylline (6'5,58'2 and 254·2 Jlmol/L, Eastman Kodak) in duplicate according to the manufacturer's instructions. The calibration data obtained was used throughout the study period of three months. The manufacturer recommends recalibration at three-monthly intervals or when the slide lot number is changed.
Reagents P (pre-treatment solution, surfactant in buffer), S (theophylline antiserum-mouse monoclonal in buffer with protein stabiliser) and T (theophylline-fluorescein tracer) were supplied in a ready-to-use pack (Theophylline II, Abbot Laboratories, Maidenhead, UK). The system was primed with buffer and the reagent pack was placed on the analyser. The turntable was loaded with disposable sample holders containing the specimens and cuvettes. Dilution of the specimens, addition of reagents, measurement of the fluorescence polarisation signal and calculation Theophylline on Kodak Ectachem nTSC 269 of the results from stored calibration data was performed automatically by the TD. analyser (Abbott Laboratories).
The analyser was calibrated with the manufacturer's human serum based calibrators (0, 13·9, 27·8,55·5, 111,222 Jlmol/L). These were analysed in duplicate and the calibration curve, which fulfilled all the manufacturer's criteria, was used throughout the study.
HIGH PERFORMANCE LIQUID
CHROMATOGRAPHY
Sample preparation
Serum (100 JlL) was mixed with 200 JlI internal standard solution (45 Jlmol/L of P-hydroxyethyltheophylline in 10% aqueous trichloroacetic acid). The tubes were allowed to stand for 15 min then centrifuged at 1000 rpm for 5-10 min. The supernatants were transferred to autojector vials for chromatography.
Chromatography
The apparatus consisted of a pump (PU4010), autojector (PU4700) and ultraviolet detector (PU4020) used at 273 nm (Pye Unicam, Cambridge, UK). Quantitation was achieved by relative peak area measurement using a data interface (SP4020) and central processor (SP4000) (Spectraphysics, Hemel Hempstead, UK). Separation was achieved using a 150 x 4·6 mm column packed with 5 um ODS (Biorad, Watford, UK) maintained at 40°C with a mobile phase of sodium acetate buffer (0'01 mol/L, pH 5·0)/ denatured ethanol/isopropanol (96: 3: I), used at a flow rate of I· 5 mL/min. Under these conditions retention times in seconds were: 1,3-dimethyluric acid 176; theobromine (3,7-dimethylxanthanine) 212; 1,7 dimethylxanthine 335; theophylline (1,3dimethylxanthine) 368; P-hydroxyethyltheophylline (internal standard) 477; 8-chlorotheophylline 623; caffeine (1,3,7-trimethylxanthine) 768.
The response to increasing serum theophylline concentrations was found to be linear over the range 0-222 Jlmol/L. Each run was calibrated by analysing a serum-based calibrator (139 Jlmol/L) in duplicate.
REFERENCES COMPOUNDS
Theophylline, theobromine, I, 7-dimethylxanthine, caffeine, I,3-dimethyluric acid and 3-methylxanthine were obtained from Sigma Chemical Co (Poole, Dorset, UK), and 3-propylxanthine (enprofylline, an analogue of theophylline) from Astra Pharmaceuticals (Kings Langley, Herts, UK). Sodium salicylate was supplied by BDH (Poole, Dorset, UK). Aqueous stock solutions were used to prepare serum pools as described below.
QUALITY CONTROL MATERIAL Serum samples were collected from three blood donations from laboratory staff. Each serum sample was tested on each analytical system and gave no detectable theophylline. Theobromine, caffeine and I, 7-dimethylxanthine concentrations were less than 10 1lmol/L when measured by HPLC. The serum samples were mixed and used to prepare three pools containing 28, 83 and 139 1lmol/L of theophylline and designated pools I, II and III. These theophylline concentrations were chosen to lie below, within and above the generally accepted therapeutic range for asthma (551 111lmol/L). Aliquots (2251lL) of each pool were stored deep-frozen and thawed as required for quality control purposes. These pools were also used in the interference experiments.
QUALITY ASSESSMENT SAMPLES
Twenty-four Iyophilised samples were obtained from the Heathcontrol National External Quality Assessment Scheme (NEQAS) for therapeutic drug measurement (Heath Park, Cardiff, UK). These were drug-free human serum samples to which theophylline was added. Some samples also contained caffeine and 1,7-dimethylxanthine.
PATIENTS' SAMPLES
Samples on which theophylline measurement was requested for monitoring of prophylactic maintenance treatment of asthma were stored deepfrozen after initial HPLC analysis. The initial results were used only to select samples for this study as there was a possibility of bias due to interference by I,7-dimethylxanthine. Forty-four specimens spread evenly over the theophylline concentration range 5-138 1lmol/L were used. These were thawed as required, mixed and analysed by all three methods. The patients' specimens were randomised with quality control and quality assessment samples into six batches for the DTSC and TD., and four batches for HPLC.
INTERFERENCE STUDIES
Pilot study
Pools containing an amount of interferent which would be potentially toxic if present in vivo (200 1lmol/L for methylxanthines and 1,3-dimethyluric acid, 7·3 mmol/L for salicylate) were prepared by adding the appropriate stock solution to the 28 1lmo1/L serum quality control pool. The results were used to select compounds for further investigation.
Detailed studies
A range ofinterferent concentrations in each QC serum pool was prepared.
Effect ofmagnesium on salicylate interference with the DTSC method A series of samples with added magnesium ion (0-50 mrnol/L) was prepared by adding aqueous magnesium chloride solution to quality control pool II (83 1lmol/L theophylline). Two series of samples, one without and one with added magnesium ion (50 mrnol/L), containing salicylate (0-7·3 mrnol/L) were prepared by addition of appropriate aqueous stock solutions or water to quality control pool II.
Effect of endogenous alkaline phosphatase on DTSC method
Theophylline was added to a number of patients' samples with high endogenous alkaline phosphatase activity so that each contained 83 1lmol/L theophylline. Theophylline was also assayed in drug-free patients' samples with raised alkaline phosphatase activities.
Results
Within-and between-bath imprecision results
obtained with the quality control pools I, II and III are shown in Table I . The DTSC method showed higher coefficients of variation than the TD, or HPLC methods for all materials except for the between-batch data for pool 1 on the TD,. However, the between-batch data for the comparative methods was rather limited.
Linear regression statistics for DTSC, TD, and HPLC results against all the laboratories trimmed mean (AL TM) for the NEQAS samples are shown in Table 2 . All three methods generally showed good agreement with the AL TM. The HPLC method however did have a statistically significant negative intercept. On patient's samples the DTSC showed excellent agreement with the TD, (Table 2 ). Both the DTSC and TD, however showed a positive bias against HPLC which could only partly be explained by the negative bias shown by HPLC on the NEQAS samples.
In the interference experiments a compound was judged not to interfere if the result from the pool with added interferent was within ± 12·5'Yo of the result for the pool without interferent. Of the potential interferents tested in the pilot study only 8-chlorotheophylline was found to interfere with theophylline measurement on the TO•. The positive bias was proportional to 8-chlorotheophylline concentration (approximately I /lmol/L positive bias in theophylline for 4 /lmol/L of 8chlorotheophylline) but independent oftheophylline concentration.
In the pilot study the OTSC was shown to be free from interference by theobromine and 1,7dimethylxanthine. Caffeine, 1,3-dimethyluric acid, 8-chlorotheophylline and 3-propylxanthine gave equivocal results in the plot study where only the effect on the highest interferent concentration in the pool with the lowest theophylline concentration was investigated. Further extended experiments showed no interference from caffeine or 8-chlorotheophylline when concentrations up to 200 /lmol/L ofcaffeine or 8-chlorotheophylline were added to any of the theophylline-containing pools. Similar experiments showed that concentrations of I,3-dimethyluric acid or 3-propylxanthine up to 200 /lmol/L did not interfere when added to pools containing 83 or 139 /lmol/L theophylline. When added to the pool containing 28 /lmol/L theophylline, 1,3-dimethyluric acid showed significant interference at concentrations greater than 100 /lmol/L and 3-propylxanthine showed interference at concentrations greater than 50 /lmol/L. Significant interference by 3methyl xanthine and salicylate in the OTSC method was evident in the pilot study. The interference by both these compounds was found to depend on both theophylline and interferent concentration (Tables 3 and 4 ).
Chelation of magnesium ions by salicylate leading to a decrease in alkaline phosphatase activity was investigated as a possible mechanism for the salicylate interference. Addition ofmagne- Recovery of theophylline (83 Jlmol/L) added to eight patients' samples with alkaline phosphatase activities from 5 to 12 times the upper limit of the reference range was between 87 and 117% and was unrelated to alkaline phosphatase activity in the sample. sium ion (50 mmol/L) to a specimen containing theophylline (83 Jlmol/L) and salicylate (7,3 mrnol/L) apparently overcame the salicylate interference. However, addition of this concentration of magnesium ion to a theophyllinecontaining serum pool caused a negative bias when compared to a similar pool without added magnesium. This finding was confirmed by the observation that magnesium ion (1'5-50 rnmol/ L) added to serum containing no theophylline increased the measured reflectance change per minute (that is, increased the baseline alkaline phosphatase activity in the slide) in proportion to the concentration added. The addition ofmagnesium ion (50 rnmol/L) decreased the measured theophylline by approximately 7 Jlmol/L in a serum pool containing theophylline (83 Jlmol/L) with little, if any, effect on the increase in measured theophylline due to the addition of salicylate (Table 4 ).
No measured theophylline was recorded in samples from patients not receiving theophylline with alkaline phosphatase activities up to 12 times the upper limit of the reference range.
Discussion
Performance criteria for theophylline measurement have been developed based on expected intra-individual variation in serum concentrations when plain tablets are given three times a day." The proposed analytical goal for imprecision was that the coefficient of variation should not exceed 12·5% over the usable analytical range of the assay. Further, it was stated that assays should be free from bias and hence the imprecision goal becomes that for total analytical error, that is, with 95% confidence all results should be within ±25% of the true value. In the present study all methods showed considerably better precision than the suggested analytical goal. Because of this we used a total error goal half of that proposed, ± 12·5%. Asjudged by agreement with comparative methods on patients' samples and by performance against the inter-laboratory consensus mean on quality assessment samples, the DTSC method is capable of meeting the stricter criteria used in this study for the majority of clinical samples.
This study confirmed earlier reports that the Abbot TD x Theophylline II assay, which uses a monoclonal antibody reagent, is free from interference by caffeine and caffeine and theophylline metabolites which might accumulate in renal impairment. It also confirmed the manufacturer's data for cross-reactivity with 8-chlorotheophylline (approximately 25% on a molar basis, independent of theophylline concentration). In a study of serum concentrations of 8-chlorotheophylline in three volunteers who took a single dose (two tablets, 1000 mg) of Dramamine, the 8chlorotheophylline salt of diphenhydramine that is available without prescription as a travel sickness remedy, we found the maximum 8chlorotheophylline concentration reached was 28 Jlmol/L. This would be expected to give a measured theophylline concentration of about 7 Jlmol/L but gave a 'none detected' reading when assayed on the TD x . The cross-reactivity of 8chlorotheophylline, except at very low serum theophylline concentrations, is therefore of little clinical significance.
The DTSC theophylline method was found to be free of interference from other rnethylxan- thines and their metabolites except for 1,3dimethyl uric acid (significant only at concentrations greater than 100 IlmoljL and at subtherapeutic theophylline concentrations) and 3methylxanthine. As 1,3-dimethyl uric acid and possibly also 3-methylxanthine may accumulate in renal impairment, the DTSC method could produce results with an unacceptable positive bias in samples from such patients. In these patients, therefore, theophylline measurements made by the DTSC method, or by some immunoassays which cross-react with 1,3-dimethyluric acid," should be interpreted with caution.
The positive bias caused by salicylate in the DTSC method was identified by the manufacturer. The interference may be of clinical importance in patients who have taken an overdose of salicylate or those treated with high dose aspirin therapy. The possibility that this is due to chelation of magnesium ions is not supported by our data or that of other workers.' In studies of the human skeletal isoenzyme using p-nitrophenol phosphate as substrate at least two sites, in addition to the magnesium binding site and the substrate binding site, affecting alkaline phosphatase activity were identified." The substrate binding site permitted competitive inhibition, for example by phosphate. The other sites were associated with uncompetitive inhibition. At one site, which bound theophylline, the uncompetitive inhibition was unaffected by the pH of enzyme activity determination. The second site of uncompetitive inhibition bound histidine and imidazole and at this site the degree of inhibition produced by a given inhibitor concentration was dependent on the pH of enzyme activity determination. We were unable to find any reference in the literature to salicylate interference in the clinical measurement of alkaline phosphatase activity. As the DTSC slide uses a lower pH than is generally used for clinical alkaline phosphatase activity measurement it is possible that salicylate interference is produced by binding to a pHdependent activity modifying site. The low pH (8'2) used may also explain the lack of interference by endogenous alkaline phosphatase.
The enzyme inhibition method for theophylline measurement proposed by Vinet and Zizian' has been criticised for its technical complexity? but the use of dry chemistry technology has allowed the development of a simplified assay protocol. The DTSC method for theophylline uses reagents with a long shelf life, a small sample size (10 ilL), requires little operator intervention other than dispensing the sample on to the slide and produces a result in less than 5 min. The results on clinical samples showed good agreement with those obtained by high performance liquid chromatography and fluorescence polarisation immunoassay. It is a useful addition to the test repertoire for the DT60 system and has a place in emergency and paediatric work where the advantage of providing a rapid result on a small sample outweighs the disadvantage of slightly greater imprecision than the comparative assays used in this study.
